Departments | |
---|---|
Book Series (90) |
1260
|
Humanities |
2246
|
Natural Sciences |
5309
|
Mathematics | 223 |
Informatics | 310 |
Physics | 971 |
Chemistry | 1346 |
Geosciences | 130 |
Human medicine | 241 |
Stomatology | 10 |
Veterinary medicine | 98 |
Pharmacy | 147 |
Biology | 812 |
Biochemistry, molecular biology, gene technology | 114 |
Biophysics | 25 |
Domestic and nutritional science | 44 |
Agricultural science | 992 |
Forest science | 202 |
Horticultural science | 18 |
Environmental research, ecology and landscape conservation | 145 |
Engineering |
1713
|
Common |
91
|
Leitlinien Unfallchirurgie
5. Auflage bestellen |
Table of Contents, PDF (57 KB)
Extract, PDF (210 KB)
ISBN-13 (Hard Copy) | 9783954049608 |
ISBN-13 (eBook) | 9783736949607 |
Language | English |
Page Number | 128 |
Lamination of Cover | matt |
Edition | 1. Aufl. |
Book Series | Hochschulschriften - Institut für Systembiotechnologie, Universität des Saarlandes |
Volume | 4 |
Publication Place | Göttingen |
Publication Date | 2015-07-13 |
General Categorization | Dissertation |
Departments |
Microbiology and biotechnology
|
Keywords | violacein, deoxyviolacein, Escherichia coli, metabolic engineering |
Violacein and deoxyviolacein are promising therapeutics against pathogenic bacteria and viruses as well as tumor cells. In the present work, systems-wide metabolic engineering was applied to Escherichia coli for heterologous production of these high-value products. First, a high performance liquid chromatography method for accurate separation and quantification of violacein and deoxyviolacein was developed. Afterwards, a basic producer, E. coli dVio-1, that expressed the vioABCE cluster from Chromobacterium violaceum under control of the araBAD promoter and induction by L-arabinose, was constructed. Targeted intracellular metabolite analysis then identified bottlenecks in pathways that supply tryptophan, the major product building block of the natural products of interest. This was used for systems-wide engineering of serine, chorismate and tryptophan biosynthesis and the non-oxidative pentose-phosphate pathway, followed by elimination of L-arabinose catabolism. Transferred to a glycerol-based fed-batch process, E. coli dVio-8 surpassed the gram scale and produced 1.6 g L-1 deoxyviolacein (> 99.5% purity). The created chassis of a high-flux tryptophan pathway was complemented by genomic integration of the vioD gene of Janthinobacterium lividum, which enabled exclusive production of violacein (710 mg L-1 with 99.8% purity). This demonstrates the potential of E. coli as a platform for production of tryptophan based therapeutics.